(Q56964373)

Stefanie Hahner

9

0 references

Massimo Terzolo

Massimo Terzolo

7

0 references

Marcus Quinkler

3

Marcus Quinkler

0 references

Martin Fassnacht

1

Martin Fassnacht

0 references

Holger S. Willenberg

5

Holger S. Willenberg

0 references

Bruno Allolio

10

Bruno Allolio

0 references

Sarah Johanssen

2

Sarah Johanssen

0 references

author name string

Peter Bucsky

4

0 references

Hans-Helge Mueller

Adrenocortical carcinoma: clinical and laboratory observations

8

0 references

language of work or name

English

0 references

publication date

24 November 2008

0 references

published in

Cancer

0 references

volume

115

0 references

issue

2

0 references

page(s)

243-250

0 references

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24030

7 January 2021

Adrenocortical carcinoma: diagnosis, evaluation and treatment

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24030

7 January 2021

Clinical review: Adrenocortical carcinoma: clinical update

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24030

7 January 2021

Extent of disease at presentation and outcome for adrenocortical carcinoma: have we made progress?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24030

7 January 2021

Clinical features of adrenocortical carcinoma, prognostic factors, and the effect of mitotane therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24030

7 January 2021

Management of adrenocortical carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24030

7 January 2021

Management of patients with adrenal cancer: recommendations of an international consensus conference.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24030

7 January 2021

Adrenocortical cancer: pathophysiology and clinical management

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24030

7 January 2021

Prognostic parameters of metastatic adrenocortical carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24030

7 January 2021

Adrenal cortical carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24030

7 January 2021

Surgical management, DNA content, and patient survival in adrenal cortical carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24030

7 January 2021

Adrenocortical carcinoma. Clinical outcome at the end of the 20th century

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24030

7 January 2021

Adrenocortical carcinomas: surgical trends and results of a 253-patient series from the French Association of Endocrine Surgeons study group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24030

7 January 2021

Optimal treatment of adrenocortical carcinoma with mitotane: results in a consecutive series of 96 patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24030

7 January 2021

Adrenal cortical carcinoma. Epidemiology and treatment with mitotane and a review of the literature

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24030

7 January 2021

Role of reoperation in recurrence of adrenal cortical carcinoma: results from 188 cases collected in the Italian National Registry for Adrenal Cortical Carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24030

7 January 2021

Clinical results of the use of mitotane for adrenocortical carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24030

7 January 2021

Clinical and biological features in the prognosis of adrenocortical cancer: poor outcome of cortisol-secreting tumors in a series of 202 consecutive patients.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24030

7 January 2021

Adrenocortical carcinoma -- improving patient care by establishing new structures

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24030

7 January 2021

Adjuvant mitotane treatment for adrenocortical carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24030

7 January 2021